Yoqneam, Israel

Went public 10/04/01 at $12 per share

Filing Range: 5.0 million shares at $12 to $14

Offering Size: $65.0 million

Post Offering Valuation: $300.8 million

Shares Outstanding: 25.1 million shares

Underwriters: Lehman Brothers/Credit Suisse First Boston/ Robertson Stephens & Co./Fidelity Capital Markets

Company Counsel: White & Case LLP

Manager Counsel: Bingham Dana LLP

Auditor: KPMG International

The Company:

Develops wireless imaging systems that provide visual examinations of the gastrointestinal tract. The company’s system uses a miniaturized video camera contained in a capsule that is ingested by the patient and delivers color images in a painless and noninvasive manner.

Venture Backers:

OrbiMed Advisors LLC

Financing Rounds:

Number of Round Amount

Round # Round Date Stage Investors ($ thousands)

1 10/01/2000 1 Early Stage 30000.0


(Data in $ million except EPS)



Total Revenues: $0.0

Net Income: (7.5)

EPS: (0.68)